Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Hormone therapy stories

Oct 16, 2026

ACOG updates menopause treatment guidelines for first time since 2014

The American College of Obstetricians and Gynecologists released updated clinical guidelines endorsing early hormone therapy for menopause symptoms, joining clinical consensus on treatment best practices after a 12-year gap.

Oct 16, 2026·2 sources
00
Aug 14, 2026

Women taking estrogen-only hormone therapy showed fewer Alzheimer's signs in brain tissue

A large study of over 2,000 women found those who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer's disease in their brains upon autopsy.

Aug 14, 2026·3 sources
00
May 31, 2026

Johnson & Johnson's Prostate Cancer Drug Reduces Risk of Cancer Spread and Death in Late-Stage Study

J&J's Erleada used with hormone-blocking therapy six months before and after prostate surgery improved cancer elimination rates and reduced the risk of cancer spread and death in a late-stage trial for prostate cancer patients.

May 31, 2026·2 sources
00
Apr 9, 2026

HRT Patches Treat Prostate Cancer as Effectively as Standard Injections with Fewer Side Effects

A large UK trial published in the New England Journal of Medicine found that women's hormone replacement therapy patches can treat prostate cancer just as effectively as standard hormone injections but with fewer severe side effects.

Apr 9, 2026·1 source
00

Top claims

  • ▪Dr. Catherine Cansino warned against oversimplifying menopause treatments into rigid tiers, stating patients may reasonably choose less effective options if fully informed
  • ▪ACOG's new menopause treatment guidelines were developed by the American College of Obstetricians and Gynecologists' Committee on Clinical Practice Guidelines in collaboration with Dr. Bruce Pier, Dr. Robert Kauffman, and Dr. Catherine Cansino
  • ▪The American College of Obstetricians and Gynecologists guidelines recommend systemic hormone replacement therapy with estrogen and progestogen for women with a uterus to mitigate endometrial cancer risk from estrogen-stimulated uterine lining growth, or estrogen alone without

Topics

Age related cognitive declineAlzheimer's diseaseDrug Policy, Pricing & ApprovalNeurodiversity & Cognitive FunctionHormone therapyWomen's healthAlzheimer’s & dementiaAging (Biology)Cognitive declineBrain longevityMental Health & WellbeingWomen's reproductive health & fertilityReproductive HealthDrug Approval and Clinical TrialsReproductive hormonesMenopause hormone therapy and symptom managementCancer & OncologyClinical trialsPharmaCancer Treatment & TherapiesCancer treatment breakthroughsCancer TypesDrug safety & pharmacovigilanceAdverse event reporting (FAERS)HealthBiomarkers & bloodwork testing

Related entities

Women's healthEstrogenOncologyUnited Kingdom